Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use

Details for Australian Patent Application No. 2009225877 (hide)

Owner GENENTECH, INC.

Inventors Berry, Leanne; Sliwkowski, Mark X.; Phillips, Gail Lewis

Agent Griffith Hack

Pub. Number AU-A-2009225877

PCT Pub. Number WO2009/117277

Priority 61/037,410 18.03.08 US

Filing date 10 March 2009

Wipo publication date 24 September 2009

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/117277 Priority application(s): WO2009/117277

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225883-Quinolizidinone M1 receptor positive allosteric modulators

2009225869-Substituted 4-hydroxypyrimidine-5-carboxamides